Dianthus Therapeutics (DNTH) Misses Q1 EPS by 82c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.82). Revenue for the quarter came in at $1.16 million.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
• Natural Gas Inventory 87 bcf vs 81 bcf Expected
• Moderna (MRNA) call put ratio 5 calls to 1 put with a focus on July 10 weekly 80 and 85 calls as share price up 6.5%